×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
For Whom the Cell Tolls: Ethics in the Era of Precision Medicine
Session Chair(s)
James Wabby, MHS
Global Head, Regulatory Affairs, Emerging Technologies and Combination Products
AbbVie, United States
This session will discuss how precision medicine will combine medicine and technology in unique ways to maximize healthcare services and outcomes. At the heart of the issue lie ethical concerns related to privacy, informed consent, and social justice.
Learning Objective : Analyze latest ethical expectations and challenges; Discuss potential future innovation platforms providing significant benefit to be gained from precision medicine; Recognize the bioethical challenges and opportunities ahead.
Speaker(s)
Bioethics Cases and Policy Development
Terry Church, DrSc, MA, MS
University of Southern California, United States
Assistant Professor, Alfred E Mann School of Pharmacy and Pharma Sciences
Ethical Frontiers: Navigating Transplant and Genetic Ethical Considerations in Patient Care
Amanda Burkhardt, PhD
University of Southern California, United States
Assistant Professor, Alfred E. Mann School of Pharmacy and Pharma Sciences
Have an account?